NDC 80534-1000
XENOVIEW
Xenon Xe 129 Hyperpolarized
XENOVIEW is a Respiratory (inhalation) Gas in the Human Prescription Drug category. It is labeled and distributed by Polarean, Inc.. The primary component is Xenon Xe-129, Hyperpolarized.
| Product ID | 80534-1000_d61a5389-0a84-465d-aacb-9407049f12d6 |
| NDC | 80534-1000 |
| Product Type | Human Prescription Drug |
| Proprietary Name | XENOVIEW |
| Generic Name | Xenon Xe 129 Hyperpolarized |
| Dosage Form | Gas |
| Route of Administration | RESPIRATORY (INHALATION) |
| Marketing Start Date | 2022-12-23 |
| Marketing Category | NDA / |
| Application Number | NDA214375 |
| Labeler Name | Polarean, Inc. |
| Substance Name | XENON XE-129, HYPERPOLARIZED |
| Active Ingredient Strength | 75 mL/L |
| NDC Exclude Flag | N |
| Listing Certified Through | 2024-12-31 |
Packaging
NDC 80534-1000-1
50 BAG in 1 CARTON (80534-1000-1) > 1 L in 1 BAG
| Marketing Start Date | 2022-12-23 |
| NDC Exclude Flag | N |
| Sample Package? | N |
Drug Details
NDC Crossover Matching brand name "XENOVIEW" or generic name "Xenon Xe 129 Hyperpolarized"
| NDC | Brand Name | Generic Name |
|---|---|---|
| 80534-1000 | XENOVIEW | xenon Xe 129 hyperpolarized |
| 80534-6350 | XENOVIEW | xenon Xe 129 hyperpolarized |
Trademark Results [XENOVIEW]
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 XENOVIEW 90135724 not registered Live/Pending |
Polarean, Inc. 2020-08-25 |
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.